Hurdle and Inuvi Join Forces to Revolutionize Healthcare: Delivering At-Home Phlebotomy Services to B2B Partners Serving the UK

[London, 09-2023] — In a groundbreaking move, Hurdle, a global leader in bio-infrastructure innovation, is thrilled to announce its strategic partnership and integration with Inuvi, a pioneer in nationwide at-home sample collection services. This collaboration will empower Hurdle’s B2B partners with seamless access to at-home phlebotomy services, reinforcing Hurdle’s commitment to driving healthcare transformation through cutting-edge solutions.

Established in 2017, Hurdle, has consistently been at the forefront of bio-infrastructure transformation. The company’s global end-to-end platform seamlessly handles biomarker and diagnostic services, serving as an essential conduit for health and wellness organisations, Hospitals, Clinical Research Organisations (CROs), Pharmaceutical companies, and the rapidly evolving telehealth sector.

Inuvi, has gained recognition for its nationwide network of nurses, phlebotomists, and healthcare professionals, enabling the swift and efficient collection of samples at-home, anytime. From appointment scheduling to secure sample delivery for laboratory testing, Inuvi manages the entire process, providing a convenient and reliable solution.

The partnership between Hurdle and Inuvi represents a monumental step towards enhancing the healthcare landscape. Through this collaboration, Hurdle’s B2B partners will gain access to further sampling options using Inuvi’s extensive network of at-home phlebotomy services, allowing for the convenient collection of samples in the comfort of patients’ homes.

“Inuvi’s expertise in sample collection and Hurdle’s commitment to innovation are a perfect match,” said Dr. Tom Stubbs, CEO at Hurdle. “This partnership not only expands our service offerings but also strengthens our value proposition to our partners. We are excited about the positive impact this collaboration will have on healthcare accessibility and convenience.”

The integration of Inuvi’s at-home phlebotomy services into the Hurdle platform will offer a range of benefits, including streamlined sample collection, faster diagnostics, and enhanced patient experiences. This strategic alliance marks a significant milestone in the journey to redefine healthcare services for the better.

For more information about Hurdle and its innovative solutions, please visit hurdle.bio.

For media inquiries or further information about the partnership, please contact: [email protected]

About Hurdle:

Hurdle, a brand of Chronomics Ltd., was founded in 2017 and is a global leader in bio-infrastructure innovation. The company’s end-to-end platform seamlessly integrates biomarker diagnostics, benefiting health and wellness organisations, Hospitals, Clinical Research Organisations (CROs), Pharmaceutical companies, and the evolving telehealth sector. Hurdle’s commitment to innovation and efficiency makes it an essential partner for organisations seeking to advance their services. For more information, visit hurdle.bio.

About Inuvi:

Inuvi is a pioneering healthcare organization with a nationwide network of nurses, phlebotomists, and health professionals. They specialise in swift and efficient sample collection services, from appointment scheduling to secure delivery for laboratory testing. Inuvi’s mission is to simplify healthcare access and provide reliable solutions to individuals and organisations in need. For more information, visit Inuvi.co.uk.

Note to Editors: High-resolution images and interviews are available upon request.